2) antiplatelet therapy
抗血小板治疗
1.
Antiplatelet therapy in patients post percutaneous coronary stent implantation;
冠状动脉内支架植入术后的抗血小板治疗
2.
Antiplatelet therapy in acute coronary syndromes;
急性冠状动脉综合征的抗血小板治疗
3.
Clinical observation of dental extraction in aged patients treated with oral anticoagulant and antiplatelet therapy
抗凝血与抗血小板治疗老年患者拔牙的临床研究
3) Antiplatelet treatment
抗血小板治疗
1.
This paper reviews the newest results and forecasts the f uture of percutaneous coronarv intervention, The most important new advances of coronary stent, di-rect myocardial revascularization, myocardial infarction, antiplatelet treatment, and restenosis are mainly discussed.
本文对经皮冠脉介入 治疗中应用的最新成果作一综述和展望,重点讨论冠状动脉内支架、直接心肌血运重建术、心肌梗死、抗血小板治疗和再狭窄的重要新进展。
4) antiplatelet agent
抗血小板药物
1.
It is well recognized that antiplatelet agent is effective in the prevention and treatment of thrombosis.
心脑血管血栓性疾病是一种常见疾病,抗血小板药物可以有效预防和治疗血栓性疾病,氯吡格雷是一种新型的具有不可逆抑制血小板聚集的噻吩并吡啶化合物。
2.
Clopidogrel——a new antiplatelet agent;
氯吡格雷是一种新颖的抗血小板药物 ,通过阻断二磷酸腺苷 (ADP)受体而抑制血小板活性。
5) Antiplatelet agents
抗血小板药物
1.
Blood perfusion-independent neuroprotection induced by antiplatelet agents and its gender-difference;
抗血小板药物的非血流灌注依赖性神经保护作用及其性别差异研究
2.
Antiplatelet agents play an important role in the treatment of ACS.
因此抗血小板药物在ACS治疗中有着重要的地位。
3.
Based on the pathophysiology of the coronary heart disease,especially acute coronary syndromes,The mechanisms,pharmacy and clinical appraisal of the antiplatelet agents were reviewed.
结合冠心病特别是急性冠脉综合征的病理生理,阐述血小板的作用机制和抗血小板药物的药理作用及临床应用。
补充资料：抗代谢类抗肿瘤药物
抗代谢类抗肿瘤药物
antimetabolite agents
此类抗癌药对核酸代谢物与酶结合反应有相互竞争作用，影响与阻断了核酸的合成，如氟尿嘧啶、甲氨蝶呤、呋喃氟尿嘧啶、阿糖胞苷等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条